photopharmics.com Open in urlscan Pro
54.196.30.232  Public Scan

Form analysis
0 forms found in the DOM

Text Content

This website stores cookies on your computer. These cookies are used to collect
information about how you interact with our website and allow us to remember
you. We use this information in order to improve and customize your browsing
experience and for analytics and metrics about our visitors both on this website
and other media. To find out more about the cookies we use, see our Privacy
Policy.

If you decline, your information won’t be tracked when you visit this website. A
single cookie will be used in your browser to remember your preference not to be
tracked.

Accept Decline
 * Follow
 * Follow
 * Follow
 * Follow

 * Clinical Pathway
 * Science
 * Patient Experience
 * Leadership
 * Newsroom
 * Investors

 * Clinical Pathway
 * Science
 * Patient Experience
 * Leadership
 * Newsroom
 * Investors

Video Player
00:03
00:00
00:21
Use Up/Down Arrow keys to increase or decrease volume.




A PERSONALIZED, AT-HOME BREAKTHROUGH

One of the most significant treatments for Parkinson’s disease in decades


ADDRESSING MAJOR UNMET NEEDS IN PARKINSON'S

With large improvements from robust clinical studies


PIVOTAL TRIAL TO CONFIRM SUSTAINED EFFICACY

Initiating remote trial of Celeste Specialized Phototherapy

NEWS – FDA GRANTS BREAKTHROUGH DESIGNATION FOR CELESTE® SPECIALIZED
PHOTOTHERAPY.

Learn more about Celeste specialized phototherapy as the only light-related
therapy to receive this FDA recognition. Be among the first to know when our
pivotal study recruiting begins. Sign Up >

NEWS – FDA GRANTS BREAKTHROUGH DESIGNATION FOR SPECIALIZED PHOTOTHERAPY.

Learn more about Celeste specialized phototherapy as the only light-related
therapy to receive this FDA recognition. Be among the first to know when our
pivotal study recruiting begins. Sign Up >


ADDRESSING MAJOR UNMET NEEDS


A BREAKTHROUGH THERAPY FOR PEOPLE LIVING WITH PARKINSON’S DISEASE

Specialized phototherapy addresses both motor and non-motor symptoms

Over 11 million people worldwide live with Parkinson’s disease (PD), a number
that is projected to double over the next 20 years. As with so many other
neurodegenerative diseases, there have been no major breakthroughs in
Parkinson’s disease in decades.

Our personalized at-home device promises to be one of the most significant
therapeutic breakthroughs in Parkinson’s disease in decades. We have seen large
improvements in our proof-of-concept studies – especially in addressing major
unmet needs in Parkinson’s. We are initiating a pivotal trial of our key
product, Celeste® specialized phototherapy, to confirm safety and sustained
efficacy.

Despite the efficacy of dopaminergic drugs, people with PD continue to
experience difficulties with unresolved motor symptoms and non-motor symptoms
(e.g., sleep disorders, fatigue, and mood and cognitive problems). Impaired
function significantly reduces quality of life for many, often preventing those
living with PD from working, exercising, socializing, and doing the things they
want to do.

We invite you to join us to improve the lives of individuals suffering from
neurodegenerative diseases.

Investor Inquiries

Do you or someone you know suffer with Parkinson’s? Click here for patient
information. 


SEEING SPECIALIZED PHOTOTHERAPY CLEARLY

Our non-invasive specialized phototherapy is well on its way to becoming a
physician-prescribed standard of care.
When it comes to motor and non-motor symptoms of Parkinson’s, here’s what we’re
seeing so far.

PROMISING RESULTS

Research participants experienced large, clinically meaningful improvements in
combined motor and non-motor function
and enjoyed improved quality of life.

NON-INVASIVE

Those who added specialized phototherapy to their existing drug regimen
experienced no major device-related side-effects or negative interactions with
their current prescriptions.

LIFESTYLE FRIENDLY PROTOCOL

Research participants found our device safe and convenient to use while watching
TV, reading, using a smart phone, or other seated activities.
More About Our Clinical Success


IMPROVING LIFE FOR PEOPLE


WITH NEURODEGENERATIVE DISEASES

While our first focus is Parkinson’s, we aim to extend our therapeutic platform
to Alzheimer’s and other neurodegenerative diseases,
promising relief and even healing for millions.

Join us in improving lives by supporting our innovation
and participating in our clinical research

Stay Connected


TRENDING TOPICS


INNOVATIVE RESEARCH, INCLUSIVE TRIALS, AND NEW FUNDING DRIVES HOPE FOR PEOPLE
WITH PARKINSON’S DISEASE

Nov 15, 2023

Innovative Research, Inclusive Trials, and New Funding Drives Hope for People
with Parkinson's Disease PhotoPharmics Secures $16 Million Investment Led by
Kickstart to Fund Pivotal Clinical Trial for FDA Market Authorization
PhotoPharmics, an innovator in Parkinson's...


CELESTE® LIGHT FOR PD TRIAL TO BE PRESENTED AT WORLD PARKINSON’S CONGRESS

Jun 22, 2023

Celeste® Light for PD Trial to be Presented at World Parkinson’s Congress
PhotoPharmics to showcase groundbreaking research at the prestigious
international event July 5-7, 2023 PhotoPharmics, a leading innovator in
Parkinson's disease, today announced that it will be...


PHOTOPHARMICS TO PRESENT AT MTI ALL STARS INVESTOR SHOWCASE

May 10, 2023

PhotoPharmics to Present at MTI All Stars Investor Showcase DeviceTalks in
Boston on May 10-11 to feature pitches from PhotoPharmics and other leading
startups PhotoPharmics today announced CEO Kent Savage has been invited to
present at the inaugural MTI All Stars...


HOW PARKINSON’S AFFECTS SLEEP AND VICE-VERSA

Mar 28, 2022

When most people think of Parkinson’s Disease (PD), the first symptom to come to
mind are physical tremors and other movement symptoms. However, most people with
Parkinson’s experience a wide range of non-motor symptoms that can often be more
disruptive to their daily...


CARE FOR THE CAREGIVERS

Nov 18, 2021

“What would I do without my caregiver?” Many people with Parkinson’s disease ask
themselves some form of this question every single day. Caregivers come in all
shapes and forms, but they all have one thing in common: The work they do is
absolutely critical. But it’s...

QUICK LINKS

 * Contact Us
 * Investors
 * Newsroom

 * Follow
 * Follow
 * Follow
 * Follow


PHOTOPHARMICS, INC.

3451 North Triumph Boulevard, Suite 201
Lehi, UT 84043 USA

Phone
+1 (801) 770-6960

© 2023 PhotoPharmics. All Rights Reserved.   |   Privacy Policy  |  Terms of Use